Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

VFC's Stock House: Immunocellular Therapeutics May Be Immune To A Broad Market Downturn

(EMAILWIRE.COM, April 10, 2012 ) New York, NY -- With a new trading quarter upon us, the broad markets as a whole look ready to take a downswing after a strong first quarter and months of running higher as the global economy demonstrated a strength and resiliency not seen for years. Although a downswing - or "correction", as some might term it - could be in the works, there are some companies and stocks out there with enough pending news, catalysts and developments that may allow them to weather the storm and outperform the near-term market trends.



Immunocellular Therapeutics (IMUC) is one that has already well-outperformed the market this year and could maintain strength into any general downswing.



Over the course of the past six months Immunocellular has emerged from one of a quite few speculative Phase II cancer immunotherapy companies to become a potential front-runner in the next generation of such treatments.



Fueled by encouraging survival data from early trials and positive developments on the business front, IMUC has soared past the two dollar mark with ease and even breached the three dollar barrier for a period, a level that the share price still flirts with on a near-daily basis, even as the market as a whole is on a breather.



Other developments and pending catalysts also bode well for both the short and long term future of Immunocellular.



For full report visit: http://vfcsstockhouse.com/blog/article/-immunocellular-therapeutics-may-be-immune-to-a-broad-market-downturn



For this week's list of stocks to watch visit: http://vfcsstockhouse.com/blog/article/-weekly-stock-watch-april-9-13-ampe-pbth-imuc-nby-nriff-cndo-siga-imsc-yhoo-fb-siri-cvm-aapl-sbux-mcd-agen



For Tuesday's stock market roundup visit: http://vfcsstockhouse.com/blog/article/-tuesday-morning-roundup-facebook-yhoo-aol-msft-imsc-ctso-cpst-sppi-amrn-cldx-ampe



About VFCsStockHouse.com:



VFC's Stock House is an information and research outlet that brings new ideas to the table and opens discussions for a broad spectrum of investors, with a strong focus on - but not limited to - biotech stocks and the pharmaceutical and healthcare sectors. VFC's Stock House provides individual company profiles, write-ups and reports as well as giving general insights into broader-market news through various 'Stock Watch' lists. At the conclusion of most weeks, VFC's Stock House issues a "Weekly Stock Watch" that examines news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well. The information contained within the pages of VFCs Stock House are not intended to be taken as advice, but as a starting point where investors can follow up with their own DD and devise their own entry and exit strategies.



Follow VFC's Stock House on Twitter: https://twitter.com/#!/VFCsStockHouse



'Like' VFC's Stock House on Facebook: http://www.facebook.com/pages/VFCs-Stock-House/143724412345213



For full disclaimer visit: http://vfcsstockhouse.com



VFC's Stock House
VFC
240-786-2111
vfc@vfcsstockhouse.com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News
Health News Headlines - Yahoo News
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on top health stories.

Germany's Bayer to launch three new Xarelto trials
29 Aug 2014 at 8:32am
Germany's Bayer unveiled plans to launch three new studies to expand the uses of its anti-clotting drug Xarelto, one of its top five new medicines. Xarelto, which competes with the Eliquis pill developed by Bristol-Myers Squibb and Pfizer in stroke prevention, reached sales of $1.7 billion in the 12 months to June. Bayer said on Friday that a Phase III trial involving about 7,000 patients would examine whether Xarelto can help prevent the recurrence of strokes in patients who have suffered strokes of undetermined cause. "We really have just as many strokes due to undetermined causes as to atrial fibrillation," Frank Misselwitz, head of the Therapeutic Area Cardiovascular and Coagulation at Bayer HealthCare, told Reuters.

Missionaries who were exposed to Ebola released from U.S. quarantine
29 Aug 2014 at 8:28am
WINSTON-SALEM N.C. (Reuters) - Missionaries who were quarantined in North Carolina to ensure they were not infected with Ebola while working in Liberia have been released without showing signs of the virus, a local government spokesman said on Friday. Health officials in Charlotte required the temporary quarantine as a precaution after three missionaries with Christian organization SIM USA returned to the United States on Aug. 10 amid the worst outbreak on record of the deadly virus. The group included two doctors who cared for Ebola patients and missionary David Writebol, whose wife Nancy was one of two American relief workers who contracted the disease that has killed more than 1,500 people in West Africa. The missionaries' 21-day health monitoring periods ended at different times depending on when each person had last been in contact with Ebola patients.

Ebola Arrives in Senegal as Outbreak Accelerates
29 Aug 2014 at 8:22am
Senegal confirms its 1st case of Ebola, underscoring W Africa outbreak is not under control

Medical charity MSF wants U.N. to take lead on Ebola epidemic
29 Aug 2014 at 8:10am
By Marine Pennetier PARIS (Reuters) - The U.N. Security Council must lead efforts to stop the Ebola epidemic in West Africa, a senior official from Medecins Sans Frontieres (MSF) said on Friday, warning the current response risked aggravating the crisis. Mego Terzian, head of the medical charity's French arm, said the epidemic was getting worse each day and neither MSF, the World Health Organisation (WHO) or the governments of Liberia, Sierra Leone and Guinea had the means to contain it. "I am extremely pessimistic if there is not a substantial international mobilisation," Terzian told Reuters in an interview in Paris. MSF is the leading private charity battling Ebola, with about 2,000 staff in the four countries - Guinea, Liberia, Sierra Leone and Nigeria - previously affected.

No respite for South Sudan: cholera down but malaria, parasitic disease up - MSF
29 Aug 2014 at 8:05am
By Katy Migiro NAIROBI (Thomson Reuters Foundation) - South Sudan's cholera crisis is waning but humanitarian workers are now battling increased cases of malaria and the parasitic disease kala azar, with children most affected. At least 10,000 people have been killed since the fighting erupted in late 2013, pitting President Salva Kiir's government forces against supporters of Riek Machar, his former deputy and longtime political rival. While a cholera outbreak appears to be under control, other diseases are plaguing South Sudan's hungry, displaced people. The latest emergency operations are focusing on malaria and kala azar, a parasitic disease transmitted by the bite of a sandfly which is usually fatal without treatment.


People Need People
29 Aug 2014 at 8:05am

Today is an example of a bad day with depression. I have shut the door, turned the lights off, closed the curtains and isolated myself from everyone. I have had numerous hours of sleep today because I cannot face the world, not even my family. This happens all the time. I lay here thinking horrible things, and it wasn't until I picked my phone...



Ebola outbreak reaches Senegal, riots break out in Guinea
29 Aug 2014 at 7:48am

By Stephanie Nebehay and Tim Cocks GENEVA/LAGOS (Reuters) - The West African state of Senegal became the fifth country to be touched by the world's worst Ebola outbreak on Friday, while riots broke out in neighboring Guinea where infection rates are rising fast. At least 1,550 people have died of Ebola and more than 3,000 have been infected since the virus was detected in the remote jungles of southeastern Guinea in March, and quickly spread across the border to Liberia and Sierra Leone. The World Health Organization warned on Thursday the actual number of cases could be up to four times higher and said that a total of 20,000 people could be infected before the outbreak ends. In the Guinean city of Nevermore, riots broke out on Thursday night over rumors that health workers had infected people with the Ebola virus, a Red Cross official and residents said.



Guinean security forces break up riot in Ebola-racked south
29 Aug 2014 at 7:40am

Riots broke out in Guinea's second-largest city Nzerekore over rumours that health workers had infected people with the deadly Ebola virus, a Red Cross official and residents said on Friday. A crowd of young men, some armed with clubs and knives, set up barricades across the southern city on Thursday and threatened to attack the hospital before security forces moved in to restore order. Gunshots were fired and several people were injured, said Youssouf Traore, president of the Guinean Red Cross. "People revolted and resorted to violence, prompting soldiers to intervene." Local Red Cross workers had to flee to the military camp with their medical equipment.



Ebola in mind, US colleges screen some students
29 Aug 2014 at 7:16am

BUFFALO, N.Y. (AP) ? College students from West Africa may be subject to extra health checks when they arrive to study in the United States as administrators try to insulate campuses from the worst Ebola outbreak in history.



McDonald's says 12 Russian branches temporarily closed
29 Aug 2014 at 6:33am

McDonald's said on Friday that a total of 12 of its branches in Russia had been temporarily closed over the state food safety regulator's allegations of sanitary violations.


Guinean student is first case of Ebola confirmed in Senegal
29 Aug 2014 at 6:23am
Senegal, a major hub for the business and aid community in West Africa, became the region's fifth country to confirm a case of Ebola on Friday after a student arrived from neighboring Guinea carrying the disease. Health Minister Awa Marie Coll Seck told a news conference the young man had turned up for treatment at a hospital in the Senegalese capital Dakar on Tuesday but concealed that he had had close contact with victims in his home country. "The results of tests carried out by the Pasteur Institute in Dakar were positive (for Ebola)," the minister said. The worst ever outbreak of the deadly virus, first detected in the jungles of southeast Guinea in March, has killed more than 1,550 people.


Train Your Brain to Thrive From 9 to 5
29 Aug 2014 at 5:35am

The majority of employers throughout the world are "strongly committed to creating a workplace culture of health" and are investing in programs to achieve these goals, according to Buck Consultants at Xerox, describing their newly released survey, "Working Well: A Global Survey of Health Promotion and Workplace Wellness Strategies." That's...



BioCryst expects to begin Ebola study in weeks
29 Aug 2014 at 4:51am

(Reuters) - BioCryst Pharmaceuticals Inc said it expects to initiate a study within weeks to test its antiviral in primates for use against Ebola infections The biotechnology company's stock was up about 5.4 percent in premarket trading after it also said it had received an additional $2.4 million in U.S. The World Health Organization has allowed for people infected in the West African epidemic to be given untested drugs, ushering in an opportunity for makers of potential therapies. This $2.4 million National Institute of Allergy and Infectious Diseases (NIAID) funding is in addition to the $22 million contract awarded to BioCryst by the agency last September. The company received $4.1 million from NIAID earlier this month to advance development of an intramuscular formulation of its drug, BCX4430.



Drug charges dropped against man over Seymour Hoffman's death: New York Times
29 Aug 2014 at 3:35am

(Reuters) - The Manhattan district attorney has dropped drug-selling charges against a jazz musician and friend of late film star Philip Seymour Hoffman, who died of an accidental drug overdose in February, the New York Times newspaper reported. Montreal-born Robert Aaron Vineberg, 58, was arrested after police traced what they believed to have been the source of the heroin suspected of killing the Oscar-winning actor. Vineberg was charged with intent to sell heroin. The district attorney said in an Aug. 14 letter that two police officers who first interrogated Vineberg after his arrest had not read him his Miranda rights -- which include the right to remain silent and the right to an attorney -- , rendering his statements to them unusable in court, the newspaper said.


Gene studies of Ebola in Sierra Leone show virus is mutating fast
29 Aug 2014 at 3:34am
By Julie Steenhuysen CHICAGO (Reuters)- Genetic studies of some of the earliest Ebola cases in Sierra Leone reveal more than 300 genetic changes in the virus as it leapt from person to person, changes that could blunt the effectiveness of diagnostic tests and experimental treatments now in development, researchers said on Thursday. It's mutating," said Pardis Sabeti of Harvard University and the Broad Institute, who led the massive study of samples from 78 people in Sierra Leone, all of whose infections could be traced to a faith healer whose claims of a cure attracted Ebola patients from Guinea, where the virus first took hold. The findings, published in Science, suggest the virus is mutating quickly and in ways that could affect current diagnostics and future vaccines and treatments, such as GlaxoSmithKline's Ebola vaccine, which was just fast-tracked to begin clinical trials, or the antibody drug ZMapp, being developed by California biotech Mapp Biopharmaceutical. The findings come as the World Health Organization said that the epidemic could infect more than 20,000 people and spread to more countries.

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC